Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-bromoethyl) diamidophosphate

EU orphan designation number: EU/3/12/966
Active ingredient: (1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-bromoethyl) diamidophosphate
Indication: Treatment of soft tissue sarcoma
Sponsor: Merck KGaA
Frankfurter Straße 250, 64293 Darmstadt, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/03/2012 Orphan designation EMA/OD/110/11 (2012)1532 of 05/03/2012
12/02/2013 Change of name and/or address of sponsor
09/03/2015 Transfer of orphan designation EMA/OD/110/11/T/01 (2015)1601 of 05/03/2015
03/06/2016 Removal of orphan designation from Community Register